Search clinical trials for: Azacitidine (AZA) with Ruxolitinib
Total 496 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminated
-
The First Affiliated Hospital with Nanjing Medical...Jiangbin Hospital Affiliated to Jiangsu University; Nanjing Second Hospital; Jiangning...Recruiting
-
Fred Hutchinson Cancer CenterCompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrimary Myelofibrosis | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
M.D. Anderson Cancer CenterKura Oncology, Inc.Not yet recruitingRefractory Acute Leukemia | Pediatric RelapsedUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingHodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterHiberCell, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompleted
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsWithdrawnLeukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Biphenotypic LeukemiaUnited States
-
The University of Texas Health Science Center,...RecruitingRecurrent EpendymomaUnited States
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterSyros Pharmaceuticals Inc.WithdrawnChronic Myelomonocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Benjamin TomlinsonRecruitingMyelodysplastic Syndromes | MDS/MPN Crossover SyndromesUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Terminated
-
Shirley Ryan AbilityLabRady Children's Hospital, San DiegoNot yet recruitingCerebral Palsy | Contracture
-
TJ Biopharma Co., Ltd.Recruiting
-
University of PittsburghWithdrawnAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; CelgeneActive, not recruitingMetastatic Melanoma | Melanoma and Other Malignant Neoplasms of SkinUnited States
-
Brian JonasNational Cancer Institute (NCI); AbbVieRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid LeukemiaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid LeukemiaUnited States
-
Zhujiang HospitalRecruitingLeukemia, Myeloid, AcuteChina
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Acute Myeloid Leukemia With Multilineage Dysplasia | Blasts 20-30 Percent of Bone Marrow Nucleated Cells | Blasts 20-30 Percent of Peripheral Blood White Cells | IPSS Risk Category Intermediate-2United States
-
Uma BorateSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7United States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Childhood Acute Myeloid Leukemia and other conditionsUnited States
-
Celyad Oncology SAWithdrawnMyelodysplastic Syndromes | AML, Adult
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Chronic Myelomonocytic Leukemia-0United States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Acute Erythroid Leukemia | Acute Megakaryoblastic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Refractory Anemia | Myelodysplastic Syndrome With Ring SideroblastsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Leukemia Cutis | Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
Medical College of WisconsinCompletedAcute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndromes | Myeloproliferative Chronic Myelomonocytic LeukemiaUnited States